BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2047999)

  • 21. Tubulo-interstitial changes in glomerulopathy. II. Prognostic significance.
    Okoń K
    Pol J Pathol; 2003; 54(3):163-9. PubMed ID: 14703282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The progression rates of different morphological forms of chronic glomerulonephritis in the pre-azotemia period (is the morphological form of chronic glomerulonephritis the factor that determines the prognosis?)].
    Riabov SI; Dobronravov VA
    Ter Arkh; 1994; 66(6):15-8. PubMed ID: 7940356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Focal and segmental glomerulosclerosis in nephrotic syndrome: a new profile of adult nephrotic syndrome in Zaire.
    Pakasa M; Mangani N; Dikassa L
    Mod Pathol; 1993 Mar; 6(2):125-8. PubMed ID: 8483881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The sialoadhesin (CD169) expressing a macrophage subset in human proliferative glomerulonephritis.
    Ikezumi Y; Suzuki T; Hayafuji S; Okubo S; Nikolic-Paterson DJ; Kawachi H; Shimizu F; Uchiyama M
    Nephrol Dial Transplant; 2005 Dec; 20(12):2704-13. PubMed ID: 16169862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A method for clinico-morphological comparisons in chronic glomerulonephritis].
    Zus' BA; Komandenko MS; Shulutko BI; Shumilkin VR; Mazurenko SO; Popugaev AI
    Ter Arkh; 1991; 63(7):91-4. PubMed ID: 1788820
    [No Abstract]   [Full Text] [Related]  

  • 26. Recurrent focal glomerulosclerosis in renal transplants.
    Axelsen RA; Seymour AE; Mathew TH; Fisher G; Canny A; Pascoe V
    Clin Nephrol; 1984 Feb; 21(2):110-2, 113-4. PubMed ID: 6373077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Possibility of predicting the development of morphologic types of chronic glomerulonephritis based on clinico-functional data].
    Ratner MIa; Serov VV; Stenina II; Varshavskiĭ VA; Rozenfel'd BI
    Klin Med (Mosk); 1988 Oct; 66(10):119-25. PubMed ID: 3236770
    [No Abstract]   [Full Text] [Related]  

  • 28. [The tubulointerstitial changes in different clinical and morphological types of chronic glomerulonephritis].
    Ratner MIa; Fedorova ND; Makurov AI
    Urol Nefrol (Mosk); 1997; (2):16-9. PubMed ID: 9206875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Tubular function disorders in the tubulo-interstitial component of chronic compensated glomerulonephritis and their clinical significance].
    Ratner MIa; Serov VV; Varshavskiĭ VA; Rozenfel'd BI; Brodskiĭ MA
    Ter Arkh; 1982; 54(7):9-13. PubMed ID: 7135232
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinico-morphologic correlations in functionally compensated chronic glomerulonephritis].
    Ratner MIa; Serov VV
    Klin Med (Mosk); 1989 Jun; 67(6):46-51. PubMed ID: 2779154
    [No Abstract]   [Full Text] [Related]  

  • 31. [Glomerular changes in interstitial kidney diseases].
    Pfaltz M; Briner J
    Schweiz Med Wochenschr; 1984 Feb; 114(6):204-9. PubMed ID: 6701502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Kidney tubule changes in the terminal stage of chronic glomerulonephritis].
    Kan'shina NF
    Arkh Patol; 1977; 39(9):43-9. PubMed ID: 588079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of intrarenal vascular sclerosis in progression of poststreptococcal glomerulonephritis.
    Gallo GR; Feiner HD; Steele JM; Schacht RG; Gluck MC; Baldwin DS
    Clin Nephrol; 1980 Feb; 13(2):49-57. PubMed ID: 7363516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The course and prognosis of mesangioproliferative glomerulonephritis].
    Shilov EM; Tareeva IE; Ivanov AA; Troepol'skaia OV; Krasnova TN; Varshavskiĭ VA; Proskurneva EP; Ivanova LV; Khudova IIu; Miroshnichenko NG
    Ter Arkh; 2002; 74(6):11-8. PubMed ID: 12136475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal interstitial fibrosis and vascular changes. Occurrence in patients with autoimmune diseases treated with cyclosporine.
    Svenson K; Bohman SO; Hällgren R
    Arch Intern Med; 1986 Oct; 146(10):2007-10. PubMed ID: 3767545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV-associated nephropathy. A unique combined glomerular, tubular, and interstitial lesion.
    Cohen AH; Nast CC
    Mod Pathol; 1988 Mar; 1(2):87-97. PubMed ID: 3070550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic allograft nephropathy: expression and localization of PAI-1 and PPAR-gamma.
    Revelo MP; Federspiel C; Helderman H; Fogo AB
    Nephrol Dial Transplant; 2005 Dec; 20(12):2812-9. PubMed ID: 16221712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Focal segmental glomerulosclerosis and hyalinosis (a review of the literature)].
    Diadyk AI; Siniachenko OV; Vasilenko IV; Shpilevaia NI
    Vrach Delo; 1986 Nov; (11):32-5. PubMed ID: 3548059
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical implications of DNA-topoisomerases examination in renal biopsies from patients with nephritis].
    Ivanova LV; Shilov EM; Ivanov AA; Kozlovskaia LV; Rudolph P; Proppe D
    Ter Arkh; 2003; 75(6):11-7. PubMed ID: 12920952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Membranoproliferative glomerulonephritis due to Hepatitis C in renal allograft.
    Al-Arrayed AS; George SM; Ratnakar KS
    Saudi Med J; 2002 Jun; 23(6):743-5. PubMed ID: 12070561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.